Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Centessa Pharmaceuticals Plc ADR (NQ: CNTA ) 13.92 +1.07 (+8.33%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Centessa Pharmaceuticals Plc ADR < Previous 1 2 3 Next > CNTA Stock Earnings: Centessa Pharmaceuticals Misses EPS for Q2 2024 August 13, 2024 CNTA stock results show that Centessa Pharmaceuticals missed analyst estimates for earnings per share the second quarter of 2024. Via InvestorPlace CNTA Stock Earnings: Centessa Pharmaceuticals Beats EPS for Q1 2024 May 13, 2024 CNTA stock results show that Centessa Pharmaceuticals beat analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace CNTA Stock Earnings: Centessa Pharmaceuticals Beats EPS for Q4 2023 March 28, 2024 CNTA stock results show that Centessa Pharmaceuticals beat analyst estimates for earnings per share the fourth quarter of 2023. Via InvestorPlace 7 Biotech Stocks Ready to Ride the Sector’s Resurgence March 18, 2024 With investors seeking new opportunities with certain segments appearing stretched, biotech stocks offer a viable canvas. Via InvestorPlace SPS Commerce Posts Upbeat Results, Joins Masonite International, Impinj And Other Big Stocks Moving Higher On Friday February 09, 2024 U.S. stocks traded mixed, with the Nasdaq Composite gaining around 100 points on Friday. Shares of SPS Commerce, Inc. (NASDAQ: SPSC) rose sharply during Friday’s session following upbeat results. Via Benzinga Topics Stocks Exposures US Equities Where Centessa Pharmaceuticals Stands With Analysts August 15, 2023 Via Benzinga Centessa Pharmaceuticals: Q1 Earnings Insights May 12, 2023 Via Benzinga Analyst Ratings for Centessa Pharmaceuticals August 11, 2022 Within the last quarter, Centessa Pharmaceuticals (NASDAQ:CNTA) has observed the following analyst ratings: Via Benzinga Why Take-Two Interactive Software Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session February 09, 2024 Shares of Take-Two Interactive Software, Inc. (NASDAQ: TTWO) fell sharply during Friday’s session following third-quarter results. Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session November 27, 2023 Via Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session July 13, 2023 Via Benzinga Centessa Culls Early-Stage Asset For Inherited Disorder August 10, 2022 Via Benzinga BMO Capital Sees Almost 300% Upside On Centessa Stock June 17, 2022 Via Benzinga IBM, ServiceNow, Lennox, Morningstar And Other Big Stocks Moving Higher On Thursday October 26, 2023 U.S. stocks traded lower, with the Nasdaq Composite falling more than 90 points on Thursday. Here are some big stocks bucking the trend and recording gains in today’s session. Via Benzinga Topics Stocks Exposures US Equities Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session July 12, 2023 Gainers Healthcare Triangle, Inc. (NASDAQ: HCTI) shares climbed 171.2% to $8.84 as the company launched initiative to prevent ransomware attacks in the $35 billion healthcare data market. Via Benzinga InMode, Daktronics, Domino's Pizza And Other Big Stocks Moving Higher On Wednesday July 12, 2023 U.S. stocks traded higher, with the Dow Jones gaining around 250 points on Wednesday. Here are some big stocks recording gains in today’s session. Via Benzinga Pancreatic Cancer Trials & New Treatments Receiving Increased Funding as Incidences of Cancer Grows June 23, 2023 Pancreatic Cancer Trials & New Treatments Receiving Increased Funding as Incidences of Cancer Grows Via News Direct Benzinga's Top Ratings Upgrades, Downgrades For June 21, 2023 June 21, 2023 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For June 12, 2023 June 12, 2023 Via Benzinga Best Buy, Abercrombie & Fitch, Burlington Stores And Some Other Big Stocks Moving Higher On Tuesday November 22, 2022 U.S. stocks traded higher, with the Dow Jones gaining around 250 points on Tuesday. Here are some big stocks recording gains in today’s session. Via Benzinga Important Biotech Catalysts For September 14, 2022 - End Of The Day Summary September 14, 2022 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For March 17, 2023 March 17, 2023 Via Benzinga FDA Grants Orphan Drug Status To Centessa's Hemophilia B Candidate September 14, 2022 Centessa Pharmaceuticals (NASDAQ: CNTA) announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to SerpinPC for the treatment of hemophilia B. A Phase 2a... Via Benzinga Morgan Stanley Downgrades Centessa Pharmaceuticals: Here's What You Need To Know August 12, 2022 Morgan Stanley downgraded its rating of Centessa Pharmaceuticals (NASDAQ:CNTA) to Underweight with a price target of $5.00, changing its price target from $10.00 to $5.00. Shares of Centessa... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For August 12, 2022 August 12, 2022 Via Benzinga Goldman Sachs Maintains Neutral Rating for Centessa Pharmaceuticals: Here's What You Need To Know August 11, 2022 Goldman Sachs has decided to maintain its Neutral rating of Centessa Pharmaceuticals (NASDAQ:CNTA) and lower its price target from $5.00 to $4.00. Shares of Centessa Pharmaceuticals are trading down... Via Benzinga Biotech Daily: Cancer Causing Impurities In Merck's Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon's Monkeypox Trial August 10, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Centessa Pharmaceuticals: Q2 Earnings Insights August 10, 2022 Centessa Pharmaceuticals (NASDAQ:CNTA) reported its Q2 earnings results on Wednesday, August 10, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Via Benzinga 89 Biggest Movers From Friday June 21, 2022 Gainers Revlon, Inc. (NYSE: REV) jumped 91.3% to close at $3.73 on Friday after the company filed for Chapter 11 bankruptcy. Via Benzinga Stocks That Hit 52-Week Lows On Friday June 03, 2022 During Friday's trading, 69 companies set new 52-week lows. Via Benzinga < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.